Joshua Garcia
Redmile Group, Llc
Assets Managed
$1.51B
Holdings
35
Last Quarter
2026 - Q1
Filed Date
19d ago
Growth Rate
11.22%(2Q avg: 21.67%)
Sustained Growth
3 quarters
Portfolio positions
This chart displays the top 10 holdings in Redmile Group, Llc's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 35 positions.
Assets under management
The assets under management (AUM) of Redmile Group, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 3 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 1.51B in assets, with a quarterly growth rate of 11.22% and a 2-quarter average growth rate of 21.67%. The portfolio is managed by Joshua Garcia, and others.
Portfolio holdings
| Investment | Portfolio % | Reported Value | Recent Activity |
|---|---|---|---|
SRRK Scholar Rock Holding Corp
| 29.52% | $445.715M 9.067M shares@ $49.16 avg price | Increased 73.67% |
KRYS Krystal Biotech Inc
| 11.53% | $173.98M 673,505 shares@ $258.33 avg price | Decreased -0.61% |
STOK Stoke Therapeutics Inc
| 8.98% | $135.584M 4.164M shares@ $32.56 avg price | Increased 3.23% |
IMNM Immunome Inc
| 8.06% | $121.573M 5.559M shares@ $21.88 avg price | Decreased -2.78% |
NRIX Nurix Therapeutics Inc
| 7.94% | $119.859M 7.733M shares@ $15.5 avg price | Decreased -4.46% |
ANNX Annexon Inc
| 5.34% | $80.606M 14.55M shares@ $5.55 avg price | Increased 44.77% |
ADCT Adc Therapeutics Sa
| 3.85% | $58.014M 15.471M shares@ $3.76 avg price | Decreased -1.25% |
RGNX Regenxbio Inc
| 2.43% | $36.611M 4.369M shares@ $8.39 avg price | |
STTK Shattuck Labs Inc
| 2.36% | $35.62M 5.54M shares@ $6.43 avg price | |
BEAM Beam Therapeutics Inc
| 1.96% | $29.493M 1.238M shares@ $23.84 avg price | Decreased -3.74% |
1-10 of 35